Contact
🔒 Contacts are masked. Get full emails & phones. Unlock via export ↗
Category
Primary
cancer · embed-ft 0.59
Tree path
Medical Health › Diseases and Conditions › Cancer
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Evidence
llms.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
Syncromune — Now Enrolling LEGION-100 Trial for mCRPC
Description
Syncromune® is developing SYNC-T®, a platform immunotherapy designed to synchronize the location of 3 key components needed to educate the immune system to recognize and attack cancer. Now enrolling LEGION-100 trial for metastatic castration-resistant prostate cancer. www.legion100trial.com
Final URL
Language
en (html)
Scanned at
2026-06-27 14:03:12